<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000674702">
  <TermName>Aurora B/C kinase inhibitor GSK1070916A</TermName>
  <TermPronunciation>(uh-ROR-uh … KY-nays in-HIH-bih-ter …)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance
          being studied in the treatment of some types of cancer. It
          blocks certain enzymes (Aurora kinases) involved in cell
          division and may kill cancer cells. It is a type of
          serine/threonine protein kinase inhibitor. Also called GSK1070916A.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000727634" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Aurora B/C kinase inhibitor GSK1070916A&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000727633" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de las cinasas Aurora B y C GSK1070916A&quot;" language="es" id="_4"/>
  <SpanishTermName>inhibidor de las cinasas Aurora B y C GSK1070916A</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de cáncer. Impide el funcionamiento de ciertas enzimas (cinasas Aurora) que participan en la división celular y es posible que destruya las células cancerosas. Es un tipo de inhibidor de la proteína cinasa serina/treonina. También se llama GSK1070916A.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-10-11</DateFirstPublished>
</GlossaryTerm>
